Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR for Sleep in MDD
NCT01189318Phase 2Withdrawn
- Sponsor
- Ewha Womans University
- Start
- Mar 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of quetiapine in major depressive disorder (MDD) (2 arms), sponsored by Ewha Womans University. Primary endpoint: Pittsburgh Sleep Quality Index at 4 weeks. Planned start Mar 2012; status: withdrawn.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01189318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189318.